Xianan Guo

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 5

Top Topics

Staphylococcus Aureus

Top Venues

Journal of evidence-based medicine

NPJ breast cancer

Expert opinion on investigational drugs

This page only lists publications with an associated author ORCID identifier.

Publications

Xianan Guo, Yunxiang Zhou, Kun Zhang, Wei Lu, Xi Zhong, Shijie Wu, Lu Shen, Huihui Chen, Yiding Chen
First-line CDK4/6 inhibitor-based combinations for HR+/HER2- advanced breast cancer: A Bayesian network meta-analysis. Journal of evidence-based medicine 17 (1) (2023)
Xianan Guo, Yunxiang Zhou, Kun Zhang, Wei Lu, Xi Zhong, Shijie Wu, Lu Shen, Huihui Chen, Yiding Chen
First-line CDK4/6 inhibitor-based combinations for HR+/HER2- advanced breast cancer: A Bayesian network meta-analysis. Journal of evidence-based medicine (2023)
Xianan Guo, Yunxiang Zhou, Kun Zhang, Wei Lu, Xi Zhong, Shijie Wu, Lu Shen, Huihui Chen, Yiding Chen
First-line CDK4/6 inhibitor-based combinations for HR+/HER2- advanced breast cancer: A Bayesian network meta-analysis. Journal of evidence-based medicine 17 (1) (2023)
Shijie Wu, Lina Qi, Huihui Chen, Kun Zhang, Jiapan He, Xianan Guo, Lu Shen, Yunxiang Zhou, Xi Zhong, Shu Zheng, Jiaojiao Zhou, Yi-Ding Chen
Functional assessment of missense variants of uncertain significance in the cancer susceptibility gene PALB2. NPJ breast cancer 8 (1) (2022)
Xianan Guo, Huihui Chen, Yunxiang Zhou, Lu Shen, Shijie Wu, Yiding Chen
Cyclin-dependent kinase inhibition and its intersection with immunotherapy in breast cancer: more than CDK4/6 inhibition. Expert opinion on investigational drugs 31 (9) (2022)